PATIENT CHOICE AWARDS

That this House notes that there are more than 1.2 million people in the UK on long-term warfarin treatment, many of whom are receiving excellent care and support in managing their condition; welcomes the first Patient Choice Awards event held in Parliament by the Anticoagulation Self-Monitoring Alliance to celebrate the excellent work that healthcare professionals are doing across the UK to support people on long-term warfarin wishing to self-monitor their blood clotting levels; congratulates the award winners for delivering the highest quality of care and professionalism for their patients; and calls on the Government to work closely with NHS England and clinical commissioning groups to ensure that the option of self-monitoring is made available to as many people on long-term warfarin as possible.